New approaches to cervical cancer screening in Latin America and the Caribbean

scientific article published on August 2008

New approaches to cervical cancer screening in Latin America and the Caribbean is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.VACCINE.2008.05.025
P698PubMed publication ID18945402
P5875ResearchGate publication ID51434505

P50authorJorge SalmerónQ58664238
Catterina FerreccioQ81746871
P2093author name stringEduardo Lazcano-Ponce
Rolando Herrero
Maribel Almonte
Gloria Ines Sánchez
José Jerónimo
P2860cites workAccuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialQ24679201
Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples.Q33321449
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisQ34642665
Human papillomavirus and Papanicolaou tests to screen for cervical cancerQ34702284
Improving cervical cancer screening in Mexico: results from the Morelos HPV Study.Q35640043
Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adoptedQ35951206
Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic reviewQ36368845
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccinationQ36537615
Chapter 15: HPV vaccine use in the developing worldQ36584364
Chapter 5: Updating the natural history of HPV and anogenital cancerQ36584420
Chapter 8: Screening for cervical cancer in developing countries.Q36584429
Chapter 9: Clinical applications of HPV testing: a summary of meta-analysesQ36584432
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.Q36695105
One-session management of cervical intraepithelial neoplasia: a solution for developing countriesQ36798476
Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingQ36815006
2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsQ36955449
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countriesQ37291430
New technologies in cervical cancer screeningQ37291434
Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean regionQ37306129
Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the CaribbeanQ37306153
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trialQ38411367
Strength of correlations between colposcopic impression and biopsy histologyQ39651855
Performance of the acetic acid test when used in field conditions as a screening test for cervical cancerQ44517232
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.Q46698348
Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in PeruQ46740868
Cost-effectiveness of cervical-cancer screening in five developing countriesQ46807926
Acetic acid visualization of the cervix: an alternative to cytologic screeningQ46889018
Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS.Q48506796
Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru.Q51917182
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study.Q51938859
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.Q51968734
Colposcopy at a crossroads.Q53346529
Number of cervical biopsies and sensitivity of colposcopy.Q53607989
Human papillomavirus and cervical cancerQ54023273
Effectiveness of cryotherapy treatment for cervical intraepithelial neoplasia.Q54299085
A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial LesionQ58475803
Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, MexicoQ58504458
Operator variability in disease detection and grading by colposcopy in patients with mild dysplastic smearsQ71088968
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa RicaQ73347438
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste ProjectQ73407381
Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinomaQ77398174
Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursorsQ77597004
Cervicography screening for cervical cancer among 8460 women in a high-risk populationQ78168517
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialQ81404025
P407language of work or nameEnglishQ1860
P921main subjectcervix uterine cancerQ160105
CaribbeanQ664609
P304page(s)L49-58
P577publication date2008-08-01
P1433published inVaccineQ7907941
P1476titleNew approaches to cervical cancer screening in Latin America and the Caribbean
P478volume26 Suppl 11